XML 133 R100.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY-BASED INCENTIVE PLANS - Nonvested Restricted Stock Activity (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
$ / shares
shares
RSAs  
Shares  
Number of nonvested shares outstanding, beginning 193,665
Nonvested shares granted 36,748
Nonvested shares vested (146,078)
Nonvested shares forfeited (16,667)
Number of nonvested shares outstanding, ending 67,668
Unrecognized stock-based compensation expense | $ $ 45
Weighted Average Grant Date Fair Value  
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares $ 3.87
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares 4.86
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares 4.27
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares 3.60
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares $ 3.63
Weighted average remaining vesting period 2 months 12 days
RSUs  
Shares  
Nonvested shares vested (803,593)
Number of nonvested shares outstanding, ending 227,376
Unrecognized stock-based compensation expense | $ $ 2,135
Restricted Shares  
Nonvested restricted stock outstanding, beginning balance (in shares) 1,408,491
Nonvested restricted stock granted (in shares) 143,978
Nonvested restricted stock vested (in shares) (657,515)
Nonvested restricted stock forfeited (in shares) (61,759)
Nonvested restricted stock outstanding, ending balance (in shares) 833,195
Weighted Average Grant Date Fair Value  
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares $ 4.31
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares 5.21
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares 4.40
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares 4.10
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares $ 4.42
Weighted average remaining vesting period 1 year 2 months 12 days
Performance Shares  
Shares  
Unrecognized stock-based compensation expense | $ $ 0
Restricted Shares  
Nonvested restricted stock outstanding, beginning balance (in shares) 1,981,464
Nonvested restricted stock granted (in shares) 0
Nonvested restricted stock vested (in shares) 0
Nonvested restricted stock forfeited (in shares) 0
Nonvested restricted stock outstanding, ending balance (in shares) 1,981,464
Weighted Average Grant Date Fair Value  
Weighted average exercise price outstanding, beginning (in usd per share) | $ / shares $ 4.61
Weighted average exercise price outstanding, nonvested options granted (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, options vested (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, options forfeited (in usd per share) | $ / shares 0
Weighted average exercise price outstanding, ending (in usd per share) | $ / shares $ 4.61
Weighted average remaining vesting period 0 days